Lenire For Tinnitus Treatment

Lenire 017

Lenire is an evidence-based treatment device proven to soothe tinnitus. Use it from the comfort of home to manage your tinnitus with the help of qualified healthcare professionals.

Lenire 015

How Does It Work?

The device plays sounds from headphones and provides gentle pulses to the tongue via a Tonguetip. The sounds and pulses work together to retrain your brain. You pay less attention to your tinnitus reducing its impact on your day-to-day life.

What Is The Device?

Bluetooth headphones, which are provided, deliver customized sounds to activate the auditory nerve to the brain. Tonguetip The Tonguetip, specifically designed to treat tinnitus, sits comfortably in the closed mouth. Tiny electrodes on the Tonguetip deliver mild and safe energy pulses to the surface of the tip of the tongue. Controller A lightweight handheld device that controls the timing and intensity of the treatment. You can start, pause and resume the treatment session, adjust the volume of the sound, and adjust the level of the tongue stimulation. The settings are customized by your healthcare professional to suit your tinnitus after an assessment to make sure you’re suitable.

Lenire 020

What Is The Research Behind Lenire?

Lenire is the first device of its kind to receive a grant of approval from the FDA to treat tinnitus. This follows a large-scale clinical trial designed to meet the FDA’s requirements during which 83% of patients recommended Lenire for the treatment of tinnitus. The large-scale trial’s results were consistent with real-world evidence from 204 patients*.

We’re a trained provider of treatment of tinnitus with Lenire. Call our office at (941) 366-2240 to book an assessment for Lenire. You can learn more about the product at www.lenire.com

Clinical Trials and Success Stories

Nature Communications Publishes Lenire Controlled Clinical Trial Paper

Lenire HeadphonesNature Communications has independently reviewed and published the results of TENT-A3, a large-scale controlled clinical trial for Lenire, the first and only FDA-Approved bimodal neuromodulation device.

Lenire Controlled Clinical Trial Takeaways
  • Lenire was shown to be more effective at providing relief from bothersome tinnitus than sound therapy alone, which was the trial’s control.
  • 112 patients took part in the controlled clinical trial.
  • 82.4% were compliant to treatment.
  • 88.6% of participants stated they would recommend Lenire to treat tinnitus.
  • No device-related serious adverse events were detected during TENT-A3.


Elliot Gerberg Video Testimonial

Elliot GerbergAll of sudden you wake up and you realise. Hey! Wait a minute! I don’t hear my tinnitus anymore!” – Elliot Gerberg, Lenire Patient.

Elliot Gerberg has lived with tinnitus for 50-years. After years of searching for a solution, he was convinced there was no nothing that could be done. That is, until, he discovered Lenire.